Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017153780) COMBINATION OF A CXCR4 ANTAGONIST AND AN IMMUNE CHECKPOINT INHIBITOR
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/153780 International Application No.: PCT/GB2017/050666
Publication Date: 14.09.2017 International Filing Date: 10.03.2017
IPC:
C07K 16/00 (2006.01) ,A61K 31/551 (2006.01) ,A61K 45/06 (2006.01)
[IPC code unknown for C07K 16][IPC code unknown for A61K 31/551][IPC code unknown for A61K 45/06]
Applicants:
PROXIMAGEN GROUP LIMITED [GB/GB]; Minerva Building 250 Babraham Research Campus Cambridge CB22 3AT, GB
Inventors:
RICHARDSON, Peter; GB
Agent:
GILL JENNINGS & EVERY LLP; The Broadgate Tower 20 Primrose Street London Greater London EC2A 2ES, GB
Priority Data:
1604213.711.03.2016GB
Title (EN) COMBINATION OF A CXCR4 ANTAGONIST AND AN IMMUNE CHECKPOINT INHIBITOR
(FR) COMBINAISON D'UN ANTAGONISTE DE CXCR4 ET D'UN INHIBITEUR DE POINT DE CONTRÔLE IMMUNITAIRE
Abstract:
(EN) The invention relates to a combination of CXCR4 antagonist 6-{4-[1 -(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide and an immune checkpoint inhibitor, and the use of the same in the treatment of tumours and/or cancers.
(FR) L'invention concerne une combinaison d'antagoniste de CXCR4 6-{4-[1-(Propan-2-yl)pipéridin-4-yl]-1,4-diazépan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide et d'un inhibiteur de point de contrôle immunitaire, et l'utilisation de ceux-ci dans le traitement de tumeurs et/ou de cancers.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)